LIFE and ARBITER.
Section of Cardiology, Rush Medical College, Rush-Presbyterian-St. Lukes Medical Center, 1653 W. Congress Parkway, Chicago, IL 60612, USA. pliebson@rush.edu
Philip R
PR
Liebson
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D000069059:Atorvastatin; D002340:Carotid Artery Diseases / Q000188:drug therapy*; D008078:Cholesterol, LDL / Q000187:drug effects; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy; D019808:Losartan / Q000627:therapeutic use*; D017035:Pravastatin / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D001262:Atenolol; D000069059:Atorvastatin; D019808:Losartan; D017035:Pravastatin